(Q44279389)

1 December 2017

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients (English)

1 reference

1 December 2017

1 reference

1 reference

Maloisel F

1

1 reference

1 December 2017

Benboubker L

2

1 reference

1 December 2017

Gardembas M

3

1 reference

1 December 2017

Coiffier B

4

1 reference

1 December 2017

Divine M

5

1 reference

1 December 2017

Sebban C

6

1 reference

1 December 2017

Blanc M

7

1 reference

1 December 2017

Abgrall JF

8

1 reference

1 December 2017

Lederlin P

9

1 reference

1 December 2017

Harousseau JL

10

1 reference

1 December 2017

Blaise AM

11

1 reference

1 December 2017

Grosbois B

12

1 reference

1 December 2017

Morice P

13

1 reference

1 December 2017

Ghandour C

14

1 reference

1 December 2017

Castaigne S

15

1 reference

1 December 2017

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

17

1 reference

1 December 2017

1

1 reference

1 December 2017

45-51

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402784

1 December 2017

0 references

cites work

Newer purine analogues for the treatment of hairy-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

The optimal management of hairy cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

Pentostatin induces durable remissions in hairy cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

Second cancer risk in hairy cell leukemia: analysis of 350 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

Infectious and immunosuppressive complications of purine analog therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

7 January 2021

Long term outcome of patients with hairy cell leukemia treated with pentostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

7 January 2021

National cancer prevalence estimation in France

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

7 January 2021

Pentostatin in the treatment of advanced hairy cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

7 January 2021

Prospective evaluation of internal adenopathy in a cohort of 43 patients with hairy cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

7 January 2021

Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

7 January 2021

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402784

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402784

1 reference

1 December 2017

1 reference